Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma.
نویسندگان
چکیده
Cerebrospinal fluid is routinely collected for the diagnosis and monitoring of patients with neurological malignancies. However, little is known as to how its constituents may change in a patient when presented with a malignant glioma. Here, we used a targeted mass-spectrometry based metabolomics platform using selected reaction monitoring with positive/negative switching and profiled the relative levels of over 124 polar metabolites present in patient cerebrospinal fluid. We analyzed the metabolic profiles from 10 patients presenting malignant gliomas and seven control patients that did not present malignancy to test whether a small sample size could provide statistically significant signatures. We carried out multiple unbiased forms of classification using a series of unsupervised techniques and identified metabolic signatures that distinguish malignant glioma patients from the control patients. One subtype identified contained metabolites enriched in citric acid cycle components. Newly diagnosed patients segregated into a different subtype and exhibited low levels of metabolites involved in tryptophan metabolism, which may indicate the absence of an inflammatory signature. Together our results provide the first global assessment of the polar metabolic composition in cerebrospinal fluid that accompanies malignancy, and demonstrate that data obtained from high throughput mass spectrometry technology may have suitable predictive capabilities for the identification of biomarkers and classification of neurological diseases.
منابع مشابه
Integrated Systems and Technologies An NMR Metabolomics Approach for the Diagnosis of Leptomeningeal Carcinomatosis
Leptomeningeal carcinomatosis (LC) is the thirdmost commonmetastatic complication of the central nervous system. However, the current modalities to reliably diagnose this condition are not satisfactory. Here, we report a preclinical proof of concept for a metabolomics-based diagnostic strategy using a rat LC model incorporating glioma cells that stably express green fluorescent protein. Cytolog...
متن کاملAttractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration.
PURPOSE There are a limited number of noninvasive methods available for the monitoring of neoplastic disease in the central nervous system. The goal of our study was to find reliable markers that could be used for disease monitoring as well as to identify new targets for the therapeutic intervention for malignant astrocytoma (WHO grades 3 and 4). EXPERIMENTAL DESIGN We employed proteomic tech...
متن کاملAn NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis
Leptomeningeal carcinomatosis (LC) is the third most common metastatic complication of the central nervous system. However, the current modalities to reliably diagnose this condition are not satisfactory. Here we report a preclinical proof of concept for a metabolomics-based diagnostic strategy, using a rat LC model incorporating glioma cells that stably expressed green fluorescent protein. Cyt...
متن کاملDrug-Induced Changes in Metabolomics of Plasma, Brain Extracellular Fluid and Cerebrospinal Fluid
متن کامل
Proteomics of gliomas: initial biomarker discovery and evolution of technology.
Gliomas are a group of aggressive brain tumors that diffusely infiltrate adjacent brain tissues, rendering them largely incurable, even with multiple treatment modalities and agents. Mostly asymptomatic at early stages, they present in several subtypes with astrocytic or oligodendrocytic features and invariably progress to malignant forms. Gliomas are difficult to classify precisely because of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Molecular & cellular proteomics : MCP
دوره 11 6 شماره
صفحات -
تاریخ انتشار 2012